Margaret Morse

Margaret Morse has held a variety of roles in their career, beginning with a Laboratory Researcher at Yale University School of Medicine in 2016. Margaret then became an Investment Banking Analyst at Morgan Stanley in 2017, followed by Co-Founder and Chairman at Tomo in 2016. In 2019, they were a Private Equity Associate at Oak Hill Capital, and in 2021 they were a New Ventures Extern at Redesign Health. Most recently, in 2022, they became an Investment Intern at Insight Partners.

Margaret Morse attended Deerfield Academy from 2009 to 2013. Margaret then went on to Yale University from 2013 to 2017, where they earned a Bachelor of Science (BS) in Molecular, Cellular and Developmental Biology. Currently, they are enrolled at Harvard Business School, where they are pursuing an MBA & MS in Biotechnology/Life Sciences.